Medicare open enrollment starts Thursday and runs until Dec. 7, letting people choose between traditional Medicare, Medicare Advantage and prescription drug plans, with changes effective Jan. 1, 2027. The Part D out-of-pocket cap rises to $2,400 from $2,100, the standard deductible increases from $615 to $700, and a temporary Part D premium subsidy will end early. Medicare-negotiated prices take effect for 15 drugs, including Ozempic, Rybelsus and Wegovy, with CMS estimating a $685 million impact on prescription drug coverage in 2027. A 3.6% Social Security cost-of-living increase adds about $75 a month for nearly 72 million beneficiaries. The Trump administration also promised one-time $90 payments in October to more than 20 million Medicare enrollees at a cost of about $2 billion, though roughly 35 million Medicare Advantage enrollees are not eligible.
Summary written by Upside AI from the original article. Read the source for full details.
Original headline: A new Medicare season begins , but some shifts will arrive in 2027
Read the original on clickondetroit.com ↗
Related news
- A new Medicare season begins , but some shifts will arrive in 2027
Medicare open enrollment starts Thursday and runs until December 7, letting people pick between traditional Medicare, privately run Medicare Advantage plans in their area, or prescription drug plans effective January 1. The Social Security Administration set a 3.6% cost-of-living increase for 2027, worth $75 more per month for nearly 72 million Social Security recipients and about 7.3 million Supplemental Security Income beneficiaries. Part D's out-of-pocket cap rises to $2,400 from $2,100, the standard deductible increases from $615 to $700, and a temporary premium subsidy ends early. New negotiated prices for 15 drugs, including Ozempic, Rybelsus and Wegovy, take effect, and CMS expects this to lower prescription drug coverage by $685 million in 2027. President Trump also announced one-time $90 payments in October for more than 20 million enrollees to help cover Part B premiums, at a cost of about $2 billion, excluding roughly 35 million Medicare Advantage enrollees.
- A new Medicare season begins , but some shifts will arrive in 2027 – Winnipeg Free Press
Medicare open enrollment runs through Dec. 7, and changes take effect on Jan. 1, 2027. The Part D annual out-of-pocket cap rises to $2,400 from $2,100, the standard deductible increases from $615 to $700, and the temporary Part D premium subsidy ends at year's end. New Medicare-negotiated prices will apply to 15 drugs, including Ozempic, Rybelsus and Wegovy, and CMS expects the change to lower prescription drug coverage for enrollees by $685 million in 2027. The Trump administration also plans one-time $90 payments in October for more than 20 million enrollees to help with Part B premiums, at a cost of about $2 billion, though roughly 35 million Medicare Advantage enrollees are not eligible. Separately, Social Security benefits will rise 3.6% in 2027, about $75 more per month for nearly 72 million recipients.
- A new Medicare season begins , but some shifts will arrive in 2027
- A new Medicare season begins , but some shifts will arrive in 2027
Medicare open enrollment begins Thursday and runs through Dec. 7, letting enrollees choose between traditional Medicare, Medicare Advantage plans and prescription drug plans, with changes effective Jan. 1. For 2027, the Part D out-of-pocket cap rises to $2,400 from $2,100, the standard deductible increases from $615 to $700, and the temporary Part D premium subsidy ends at year's end. New Medicare-negotiated prices take effect for 15 drugs, including Ozempic, Rybelsus and Wegovy, which CMS expects to lower prescription drug coverage costs by $685 million in 2027. President Trump also promised one-time $90 payments in October to more than 20 million Medicare enrollees for Part B premiums, at a cost of roughly $2 billion, while about 35 million Medicare Advantage enrollees are not eligible. Social Security benefits will rise 3.6% in 2027, about $75 more per month for nearly 72 million recipients.
- A new Medicare season begins , but some shifts will arrive in 2027
Medicare open enrollment starts Thursday and runs through Dec. 7, letting people choose between traditional Medicare, Medicare Advantage plans and prescription drug plans for coverage starting Jan. 1, 2027. The Social Security cost-of-living adjustment rises 3.6% in 2027, adding $75 a month for nearly 72 million beneficiaries and about 7.3 million people on Supplemental Security Income. The Part D out-of-pocket cap rises to $2,400 from $2,100, the standard deductible increases from $615 to $700, and a temporary federal Part D premium subsidy ends early at year's end. Medicare-negotiated prices for 15 drugs, including Ozempic, Rybelsus and Wegovy, take effect Jan. 1, and CMS expects the change to lower prescription drug coverage for enrollees by $685 million in 2027. Trump said one-time $90 payments will go out in October to more than 20 million enrollees to help with Part B premiums, costing about $2 billion, but roughly 35 million Medicare Advantage enrollees are excluded.
- A new Medicare season begins , but some shifts will arrive in 2027
Medicare open enrollment starts Thursday and runs until December 7, as enrollees face changes taking effect in 2027, amid inflation pressure on seniors and midterm elections weeks away. The Part D out-of-pocket cap rises to $2,400 from $2,100 in 2026, the standard deductible increases from $615 to $700, and the temporary Part D premium subsidy ends early. Medicare-negotiated prices for 15 drugs, including Ozempic, Rybelsus and Wegovy, take effect in 2027, and CMS expects this to lower prescription drug coverage for enrollees by $685 million. Social Security benefits will rise 3.6%, or $75 more per month for nearly 72 million recipients, and the increase also translates to extra payments for about 7.3 million SSI beneficiaries. President Trump also announced $90 one-time payments in October for more than 20 million people paying Part B premiums, and roughly 1 million people will receive $500 rebate checks for ACA premiums.
Related markets
Latest news
- Bitcoin ETFs just saw their biggest day in a month thanks entirely to BlackRock
U.S. spot bitcoin ETFs took in $526.6 million on Monday, the largest daily net inflow in nearly a month, driven entirely by BlackRock's iShares Bitcoin Trust (IBIT), which pulled in $665.2 million, its biggest daily inflow since Oct. 7 last year, according to SoSoValue data. Fidelity's FBTC lost $83.6 million and Grayscale's GBTC shed $54.9 million, while the remaining funds recorded no net flows. The inflow more than erased last week's $228.5 million of withdrawals, but funds remain about $90.5 million in net outflows for October, according to CoinDesk calculations. Ether funds moved the opposite way, losing $103.3 million in their fourth consecutive session of outflows, with BlackRock's ETHA accounting for $95.4 million of that.
- A Big4 bank cut deposit rates in the morning, then raised them again in the afternoon
VietinBank cut its deposit rates for terms of 6 months and longer on the morning of Oct. 20, then restored them to pre-adjustment levels by the afternoon. Its afternoon rate board showed 3.5% per year for 6 to under 12 months, 5.9% for 12 to under 24 months and 6% for 24 months and longer, versus 3%, 5.4% and 5.5% in the morning. Rates for terms under 6 months stayed unchanged, including 2.1% for 1 to under 3 months and 2.4% for 3 to under 6 months. The move came as banks followed the State Bank of Vietnam's guidance to cut deposit rates by at least 0.5 percentage points for terms of 6 months and longer, and Vietcombank and Agribank were among those reducing rates.
- IVV vs. SPY: Which S&P 500 ETF Is the Better Buy for Long-Term Investors?
The article compares two ETFs that track the S&P 500, iShares Core S&P 500 ETF (IVV) and State Street SPDR S&P 500 ETF (SPY), which have nearly identical holdings. The main difference is the expense ratio: IVV charges 0.03% a year, one-third of SPY's 0.09%, and its distribution yield is about 1.1% versus 1% for SPY. SPY's high liquidity remains valuable for active traders. The article concludes that IVV is the better choice for long-term investors, since lower costs can compound over time.
- Warren Buffett Is Issuing a Stark Warning About the Stock Market. Here's What History Says Comes Next.
Warren Buffett has warned that investors are taking on too much risk, likening the market to 'a church with a casino attached' and saying people have never been in a more gambling mood. The article points to the S&P 500 Shiller CAPE Ratio, which has stayed above 40 since May of this year; historically, the only other time it held above that level for months was during the dot-com bubble, when it peaked around 44 before the bear market began in March 2000. The article notes that 40 is not an automatic trigger for a downturn, and no metric can predict timing. It suggests investors focus on quality stocks with solid fundamentals and be ready to hold them for at least a few years.
- Early Uber Investor Jason Calacanis Predicts Waymo Could Buy Lucid Or Rivian — Calls Its Chinese-Car Optics ‘Really Bad’
Early Uber investor Jason Calacanis predicts Waymo will buy Lucid Group (LCID) or Rivian Automotive (RIVN), arguing that its reliance on Chinese-made Zeekr vehicles creates cost and reputational problems. He says the arrangement is technically not illegal today, but Waymo would need to pay a tariff of over 100%, and it has drawn national-security concerns on Capitol Hill. According to Semafor, Waymo aims to grow its fleet from about 4,000 vehicles to 8,000 by the end of 2026 and 20,000 by the end of 2027, after closing a $5 billion term loan and a $16 billion equity raise this year. Uber has committed to buying at least 35,000 Lucid vehicles, while its Rivian deal starts with 10,000 autonomous R2 SUVs, with rides expected to begin in 2028. Calacanis, who recently bought small stakes in Lucid, Rivian, WeRide (WRD) and Pony.ai (PONY), expects consolidation in the autonomous-driving sector within 24 months.
- Prediction: Oct. 21 Will Be a Huge Day for the Stock Market
The article predicts October 21 could be a pivotal day for the stock market, as Meta Platforms (META) becomes the first of the "Magnificent Seven" tech giants to report third-quarter earnings after the close. In its latest quarter, Meta's total revenue rose 28% to $60 billion, with ad revenue at $59 billion. Investors will be watching whether its capital spending, now about 35% of revenue, is translating into growth. Meta's report could hint at the earnings outlook for other tech giants and set the direction for the S&P 500 in the coming days, with the first trading session after the report on Thursday.
Get the briefing on Telegram or Zalo
Join the Upside Telegram channel or Zalo group for the Vietnam stocks and gold briefing at 8:00 and 19:00 (Vietnam time) on trading days, plus a weekly wrap on Saturday morning.